Issue Brief: Medications for Opioid and Alcohol Use Disorders: Research Insights for Criminal Justice Professionals

Key Takeaways Medications for Substance Use Disorders Are Effective Treatments. Methadone, buprenorphine, and naltrexone are FDA-approved medications for the treatment of opioid use disorder (OUD). Naltrexone, acamprosate, and disulfiram are FDA-approved medications for the treatment of alcohol use disorder (AUD). These medications are effective in reducing substance use and improving recovery outcomes. Patient Choice Matters.…

Read More

Issue Brief: Treating Opioid Use Disorder in Justice-Involved Populations

Download the Issue Brief (PDF) Opioid use disorder (OUD) is a medical condition that is treatable. Individuals involved in the criminal justice system should be screened for OUD. Anyone with moderate to severe OUD should have access to medication treatment for OUD in all criminal justice settings and upon release. OUD is a treatable illness,…

Read More

Survey of Turnkey Clinics Staff (050)

Correctional medical staff have been on the front lines of the current COVID-19 pandemic. Medical staff working in prisons and jails are responsible for providing healthcare in very challenging correctional environments. As county jails have been among the hotspots for COVID-19 related outbreaks, it is imperative to better understand perceptions of COVID-19 related risk, experiences…

Read More

An Implementation Process Evaluation for the Planning Initiative to Build Bridges between Jail and Community Treatment for Opioid Use Disorder

The Building Bridges planning initiative focused on preparing sites to establish effective linkages between jails and community-based treatment settings in order to deliver medications for opioid use disorder (MOUD) to justice-involved people. This 9-month planning initiative was jointly funded and led by the Bureau of Justice Assistance (BJA) and Arnold Ventures. Building Bridges was designed…

Read More